The Venture Codex Logo

The Venture Codex

Nolan Capital

338 Pier Ave, Hermosa Beach, CA, 90254, United States

Overview

Real estate and investment company.

Founded

2014

Deals ยท 12mo

1

Links

WebsiteLinkedIn

Stage focus

Multi-stage

Geographic focus

United States

Sector focus

Asset Management
Finance
Financial Services

Investment portfolio

6rounds
NAMEDATESIZE
Encoded Therapeutics
Sep 2026Participated
$275 MSeries F
Palvella Therapeutics
Jan 2023Participated
$38 MSeries D
Jaguar Gene Therapy
Apr 2021Participated
$139 MSeries B
Encoded Therapeutics
Jul 2020Participated
$135 MSeries D
Palvella Therapeutics
May 2020Participated
$45 MSeries C
Taysha Gene Therapies
Apr 2020Led
$30 MSeed
Encoded Therapeutics
Sep 2026Participated
$275 MSeries F
Palvella Therapeutics
Jan 2023Participated
$38 MSeries D
Jaguar Gene Therapy
Apr 2021Participated
$139 MSeries B
Encoded Therapeutics
Jul 2020Participated
$135 MSeries D
Palvella Therapeutics
May 2020Participated
$45 MSeries C
Taysha Gene Therapies
Apr 2020Led
$30 MSeed
6
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Nolan Capital: 6 funding rounds are recorded in the selected participation categories.All available history.
Nolan Capital: 6 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Seed10
Series B01
Series C+04

Monthly Deal Activity

Nolan Capital: 6 deals are recorded across 79 months.All available history.
Nolan Capital: 6 deals are recorded across 79 months. All available history
MonthDeals
Apr '201
May '201
Jun '200
Jul '201
Aug '200
Sep '200
Oct '200
Nov '200
Dec '200
Jan '210
Feb '210
Mar '210
Apr '211
May '210
Jun '210
Jul '210
Aug '210
Sep '210
Oct '210
Nov '210
Dec '210
Jan '220
Feb '220
Mar '220
Apr '220
May '220
Jun '220
Jul '220
Aug '220
Sep '220
Oct '220
Nov '220
Dec '220
Jan '231
Feb '230
Mar '230
Apr '230
May '230
Jun '230
Jul '230
Aug '230
Sep '230
Oct '230
Nov '230
Dec '230
Jan '240
Feb '240
Mar '240
Apr '240
May '240
Jun '240
Jul '240
Aug '240
Sep '240
Oct '240
Nov '240
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '250
Nov '250
Dec '250
Jan '260
Feb '260
Mar '260
Apr '260
May '260
Jun '260
Jul '260
Aug '260
Sep '261
Oct '260

Sector Breakdown

Nolan Capital: Health & Life Sciences is the largest displayed sector by deal count (6 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Nolan Capital: Health & Life Sciences is the largest displayed sector by deal count (6 deals). All available history
SectorDeals
Health & Life Sciences6
Consumer & Lifestyle1

Deal Size Distribution

Nolan Capital: 6 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Nolan Capital: 6 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M0
$5M-$10M0
$10M-$25M0
$25M-$50M3
$50M-$100M0
$100M-$250M2
$250M-$500M1
$500M-$1B0
$1B+0

Deals By Geography

Nolan Capital: United States has the largest recorded deal count among the displayed regions (6 deals).All available history.

Top 1 of 1 regions; European countries are grouped as Europe.

Nolan Capital: United States has the largest recorded deal count among the displayed regions (6 deals). All available history
RegionDeals
United States6
Nolan Capital: 20 co-investors are shown, with ARCH Venture Partners sharing 3 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Nolan Capital: 20 co-investors are shown, with ARCH Venture Partners sharing 3 recorded deals. All available history
Co-investorShared deals
ARCH Venture Partners3
Agent Capital2
BioAdvance2
BVF Partners2
Farallon Capital Management2
Google Ventures2
Illumina Ventures2
Matrix Capital Management2
RTW Investments2
Samsara BioCapital2
SoftBank2
Adams Street Partners1
Boxer Capital1
Braidwell1
CAM Capital1
Deerfield Management1
Eli Lilly and Company1
Goldman Sachs1
Gore Range Capital1
HBM Genomics1

Investment Strategy

Nolan Capital: Led accounts for 17% and participating for 83% of round participation.All available history.
Nolan Capital: Led accounts for 17% and participating for 83% of round participation. All available history
CategoryDeals (count)Share (%)
Led117%
Participating583%
Nolan Capital: Single-lead accounts for 0% and co-led for 100% of lead dynamics.All available history.
Nolan Capital: Single-lead accounts for 0% and co-led for 100% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead00%
Co-led1100%

Team

Peter Nolan

President